companydata.dkcompanydata.dk

Signum Life Science ApS: Financial statements 2017

CVR: 36559241

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 12,527,562 and a net result of DKK 5,500,937 compared with DKK 4,835,572 the year before. That is an increase of 10.1% compared with the year before. Equity in the 2017 report amounted to DKK 125,776,335. The solvency ratio was 84.4%.

Gross Profit
DKK 12,527,562
Profit/Loss
DKK 5,500,937
Equity
DKK 125,776,335
Total Assets
DKK 149,036,404

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-12.5M5.5M125.8M-
2016-11.4M4.8M122.5M16
2015-9.2M2.6M119.5M16

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Signum Life Science ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

Christina Dyreborg Jeppesen joins the board of Signum Life Science ApSNov 16, 2017

As of November 16, 2017, Christina Dyreborg Jeppesen has joined the board of directors of Signum Life Science ApS.

Henriette Rosenquist joins the board of Signum Life Science ApSNov 16, 2017

As of November 16, 2017, Henriette Rosenquist has joined the board of directors of Signum Life Science ApS.

Julie Enevold Brooker joins the board of Signum Life Science ApSNov 16, 2017

As of November 16, 2017, Julie Enevold Brooker has joined the board of directors of Signum Life Science ApS.

Lasse Richter Petersen leaves the board of Signum Life Science ApSNov 16, 2017

As of November 16, 2017, Lasse Richter Petersen has left the board of directors of Signum Life Science ApS.

Christophe Duret leaves the board of Signum Life Science ApSNov 16, 2017

As of November 16, 2017, Christophe Duret has left the board of directors of Signum Life Science ApS.

Signum Life Science ApS: The 2016 annual report is outMay 22, 2017

Signum Life Science ApS has published its annual report for 2016. Gross profit came to DKK 11,381,989, and the net result was DKK 4,835,572.

Anders Thelborg joins the board of Signum Life Science ApSApr 5, 2017

As of April 5, 2017, Anders Thelborg has joined the board of directors of Signum Life Science ApS.

Jan Fritzbøger leaves the board of Signum Life Science ApSApr 5, 2017

As of April 5, 2017, Jan Fritzbøger has left the board of directors of Signum Life Science ApS.

Mads Tang Dalsgaard leaves the board of Signum Life Science ApSApr 5, 2017

As of April 5, 2017, Mads Tang Dalsgaard has left the board of directors of Signum Life Science ApS.

About Signum Life Science ApS

Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.

Source: annual report 2025, Danish Business Authority